JRSH significantly expanded operations with 24% revenue growth and 71% capacity increase while successfully pivoting away from PPE business back to core sportswear manufacturing.
The company demonstrates strong operational momentum with substantial capacity expansion from 14 million to 24 million pieces annually and meaningful revenue growth, while improving profitability from operating losses to $1.4M operating income. However, the 265% increase in interest expense and deteriorating cash flow generation suggest the expansion may be debt-financed and operationally challenging in the near term.
JRSH delivered strong top-line growth with 24% revenue increase to $145.8M and significant profitability improvement, swinging from -$665K to $1.4M operating income. However, operational efficiency declined as evidenced by 45% drop in operating cash flow despite higher profits, while interest expense surged 265% and total liabilities increased 27%, indicating debt-funded expansion. The mixed financial picture shows growth momentum tempered by increased leverage and cash generation challenges.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Interest expense surged 264.8% — significant debt increase or rising rates materially impacting earnings.
Net income grew 57.7% — bottom-line growth signals improving overall business health.
Operating cash flow fell 45.1% — earnings quality concerns; investigate working capital changes and non-cash items.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Current liabilities surged 34.1% — significant near-term obligations; verify ability to meet short-term debt.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Liabilities increased 27.1% — monitor debt-to-equity ratio and interest coverage.
Revenue growing 24.4% — solid top-line momentum, watch margins for quality of growth.
Capex reduced 23.4% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →